Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation

Journal of Hepatology

Volumn 58, Issue 5, 2013, Pages 962-968

  Manousou, Pinelopi ^a   Burroughs, Andrew K ^a   Sochatzis, Emmanuel T ^a   Isgro, Grazia ^a   Hall, Andrew ^b   Green, Anna ^b   Calvaruso, Vincenza ^a,e   Ma, Guang Li ^c   Gale, Jeremy ^c   Burgess, Gary ^f   O'Beirne, James ^a   Patch, David ^a   Thorburn, Douglas ^a   Leandro, Gioacchino ^d   Dhillon, Amar Paul ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c PFIZER INC   (United States)

^d IRCCS 'De BELLIS' Castellana Grotte   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f University of Palermo ^*  (United States)

Author keywords

Collagen; Digital image analysis; Fibrosis progression; Liver transplantation; Recurrent HCV

Indexed keywords

AZATHIOPRINE; COLLAGEN; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; ASCITES; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; ISHAK STAGING; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; ORGAN DONOR; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BIOPSY; COHORT STUDIES; COLLAGEN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84876288298     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.12.016     Document Type: Article

References (50)

1. R.A. Standish, E. Cholongitas, A. Dhillon, A.K. Burroughs, and A.P. Dhillon An appraisal of the histopathological assessment of liver fibrosis Gut 55 2006 569 578
2. G. Germani, P. Hytiroglou, A. Fotiadu, A.K. Burroughs, and A.P. Dhillon Assessment of fibrosis and cirrhosis in liver biopsies: an update Semin Liver Dis 31 2011 82 90
3. G. Germani, A.K. Burroughs, and A.P. Dhillon The relationship between liver disease stage and liver fibrosis: a tangled web Histopathology 57 2010 773 784
4. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
5. W. Jimenez, A. Pares, J. Caballeria, D. Heredia, M. Bruguera, and M. Torres Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method Hepatology 5 1985 815 818
6. V. Calvaruso, A.K. Burroughs, R. Standish, P. Manousou, F. Grillo, and G. Leandro Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient Hepatology 49 2009 1236 1244
7. P. Manousou, A.P. Dhillon, G. Isgro, V. Calvaruso, T.V. Luong, and E. Tsochatzis Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation Liver Transpl 17 2011 178 188
8. V. Calvaruso, A.P. Dhillon, E. Tsochatzis, P. Manousou, F. Grillo, and G. Germani Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation J Gastroenterol Hepatol 27 2012 1227 1232
9. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
10. T. Poynard, J. McHutchison, M. Manns, C. Trepo, K. Lindsay, and Z. Goodman Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 2002 1303 1313
11. J.R. Lake The role of immunosuppression in recurrence of hepatitis C Liver Transpl 9 2003 S63 S66
12. M. Berenguer Host and donor risk factors before and after liver transplantation that impact HCV recurrence Liver Transpl 9 2003 S44 S47
13. R.H. Wiesner, M. Sorrell, and F. Villamil Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C Liver Transpl 9 2003 S1 S9
14. L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, and M.R. Lucey The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
15. T. Poynard, V. Ratziu, F. Charlotte, Z. Goodman, J. McHutchison, and J. Albrecht Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C J Hepatol 34 2001 730 739
16. J. Macias, J. Berenguer, M.A. Japon, J.A. Giron, A. Rivero, and L.F. Lopez-Cortes Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus Hepatology 50 2009 1056 1063
17. P.D. Griffiths, A.V. Cope, A.F. Hassan-Walker, and V.C. Emery Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation Transpl Infect Dis 1 1999 179 186
18. D.N. Samonakis, G. Germani, and A.K. Burroughs Immunosuppression and HCV recurrence after liver transplantation J Hepatol 56 2012 973 983
19. D.N. Samonakis, C.K. Triantos, U. Thalheimer, A. Quaglia, G. Leandro, and R. Teixeira Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation Liver Transpl 11 2005 386 395
20. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
21. E. Cholongitas, A. Quaglia, D. Samonakis, M. Senzolo, C. Triantos, and D. Patch Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut 55 2006 1789 1794
22. A.R. Crawford, X.Z. Lin, and J.M. Crawford The normal adult human liver biopsy: a quantitative reference standard Hepatology 28 1998 323 331
23. G.S. Datta, M. Hudson, A.K. Burroughs, R. Morris, K. Rolles, and P. Amlot Grading of cellular rejection after orthotopic liver transplantation Hepatology 21 1995 46 57
24. K. Rolles, B.R. Davidson, and A.K. Burroughs A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin Transplantation 68 1999 1195 1198
25. J.G. O'Grady, A. Burroughs, P. Hardy, D. Elbourne, and A. Truesdale Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial Lancet 360 2002 1119 1125
26. P. Manousou, D. Samonakis, E. Cholongitas, D. Patch, J. O'Beirne, and A.P. Dhillon Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy Liver Transpl 15 2009 1783 1791
27. N. Yilmaz, M.L. Shiffman, R.T. Stravitz, R.K. Sterling, V.A. Luketic, and A.J. Sanyal A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation Liver Transpl 13 2007 975 983
28. D.N. Samonakis, E. Cholongitas, U. Thalheimer, G. Kalambokis, A. Quaglia, and C.K. Triantos Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis Liver Transpl 13 2007 1305 1311
29. J.F. Gallegos-Orozco, A. Yosephy, B. Noble, B.A. Aqel, T.J. Byrne, and E.J. Carey Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course Liver Transpl 15 2009 1872 1881
30. G.J. McKenna, J.F. Trotter, E. Klintmalm, N. Onaca, R. Ruiz, and L.W. Jennings Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression Am J Transpl 11 2011 2379 2387
31. M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim, and M. Rayon HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 32 2000 673 684
32. G. Kalambokis, P. Manousou, D. Samonakis, F. Grillo, A.P. Dhillon, and D.W. Patch Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient Transpl Int 22 2009 172 181
33. M. Berenguer, M. Prieto, F. San Juan, J.M. Rayon, F. Martinez, and D. Carrasco Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202 210
34. U.P. Neumann, T. Berg, M. Bahra, G. Puhl, O. Guckelberger, and J.M. Langrehr Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 77 2004 226 231
35. Y.H. Oo, T. Dudley, P. Nightingale, G. Haydon, and D. Mutimer Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation Liver Transpl 14 2008 81 87
36. G.T. Everson Impact of immunosuppressive therapy on recurrence of hepatitis C Liver Transpl 8 2002 S19 S27
37. G.V. Papatheodoridis, S. Davies, A.P. Dhillon, R. Teixeira, J. Goulis, and B. Davidson The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 72 2001 412 418
38. M.R. Foxton, A. Quaglia, P. Muiesan, M.A. Heneghan, B. Portmann, and S. Norris The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C Am J Transpl 6 2006 1922 1929
39. S.C. Rayhill, Y.M. Wu, D.A. Katz, M.D. Voigt, D.R. Labrecque, and P.A. Kirby Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C Transplantation 84 2007 331 339
40. M. Wali, R.F. Harrison, P.J. Gow, and D. Mutimer Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C Gut 51 2002 248 252
41. D.J. Mutimer, B. Gunson, J. Chen, J. Berenguer, P. Neuhaus, and D. Castaing Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus Transplantation 81 2006 7 14
42. M. Berenguer, V. Aguilera, M. Prieto, F. San Juan, J.M. Rayon, and S. Benlloch Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients Liver Transpl 12 2006 762 767
43. G. Germani, M. Pleguezuelo, F. Villamil, S. Vaghjiani, E. Tsochatzis, and L. Andreana Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil Am J Transpl 9 2009 1725 1731
44. M. Berenguer, J. Crippin, R. Gish, N. Bass, A. Bostrom, and G. Netto A model to predict severe HCV-related disease following liver transplantation Hepatology 38 2003 34 41
45. T. Walter, J. Dumortier, O. Guillaud, V. Hervieu, P. Paliard, and J.Y. Scoazec Rejection under alpha interferon therapy in liver transplant recipients Am J Transpl 7 2007 177 184
46. A.J. Eid, R.A. Brown, C.V. Paya, and R.R. Razonable Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus Transplantation 84 2007 511 516
47. J. Hunt, F.D. Gordon, W.D. Lewis, E. Pomfret, J.J. Pomposelli, and R.L. Jenkins Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens Liver Transpl 7 2001 1056 1063
48. U.P. Neumann, T. Berg, M. Bahra, D. Seehofer, J.M. Langrehr, and R. Neuhaus Fibrosis progression after liver transplantation in patients with recurrent hepatitis C J Hepatol 41 2004 830 836
49. S. Gawrieh, B.G. Papouchado, L.J. Burgart, S. Kobayashi, M.R. Charlton, and G.J. Gores Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation Liver Transpl 11 2005 1207 1213
50. G. Isgro, V. Calvaruso, L. Andreana, T.V. Luong, M. Garcovich, and P. Manousou The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis J Gastroenterol 2012 PMID 23124603 [Epub ahead of print]